Katherine Bach Kalin Sellas Life Sciences Group, Inc. (SLS) insider trading activity

Katherine Bach Kalin is Director of SELLAS Life Sciences Group, Inc.. Currently has a direct ownership of 104,400 shares of SLS, which is worth approximately $149,292. The most recent transaction as insider was on Nov 19, 2025, when has been sold 63,400 shares (Common Stock) at a price of $1.59 per share, resulting in proceeds of $100,806. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 104K

154.63% 3M change

1128.24% 12M change

Total Value Held $149,292

Katherine Bach Kalin Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Nov 19 2025	BUY Open market or private purchase	$100,806 $1.59 p/Share	63,400 Added 37.78%	104,400 Common Stock
May 22 2025	BUY Open market or private purchase	$36,000 $1.8 p/Share	20,000 Added 32.79%	41,000 Common Stock
Jan 10 2025	BUY Grant, award, or other acquisition	-	12,500 Added 37.31%	21,000 Common Stock
Jan 22 2024	BUY Grant, award, or other acquisition	-	6,000 Added 41.38%	8,500 Common Stock
Feb 02 2023	BUY Grant, award, or other acquisition	-	2,500 Added 50.0%	2,500 Common Stock

Also insider at

ATHX

ATHERSYS, INC Healthcare

Director

KBK